These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23443916)

  • 1. Breast cancer and the environment: what is left to learn?: A Countercurrents Series.
    Narod SA
    Curr Oncol; 2013 Feb; 20(1):8-9. PubMed ID: 23443916
    [No Abstract]   [Full Text] [Related]  

  • 2. Countercurrents: A new kind of breast cancer gene mutation: A Countercurrents Series.
    Narod SA
    Curr Oncol; 2013 Apr; 20(2):88-9. PubMed ID: 23559870
    [No Abstract]   [Full Text] [Related]  

  • 3. Early-onset breast cancer: what do we know about the risk factors?: A Countercurrents Series.
    Narod SA
    Curr Oncol; 2011 Oct; 18(5):204-5. PubMed ID: 21980244
    [No Abstract]   [Full Text] [Related]  

  • 4. Salpingectomy to prevent ovarian cancer: A Countercurrents Series.
    Narod SA
    Curr Oncol; 2013 Jun; 20(3):145-7. PubMed ID: 23737681
    [No Abstract]   [Full Text] [Related]  

  • 5. Do acronyms belong in the medical literature?: A Countercurrents Series.
    Narod SA; Ahmed H; Akbari MR
    Curr Oncol; 2016 Oct; 23(5):295-296. PubMed ID: 27803592
    [No Abstract]   [Full Text] [Related]  

  • 6. The tip of the iceberg: a countercurrents series.
    Narod SA
    Curr Oncol; 2012 Jun; 19(3):129-30. PubMed ID: 22670089
    [No Abstract]   [Full Text] [Related]  

  • 7. Earlier age of onset in BRCA carriers-anticipation or cohort effect?: A Countercurrents Series.
    Narod SA
    Curr Oncol; 2011 Dec; 18(6):257-8. PubMed ID: 22184484
    [No Abstract]   [Full Text] [Related]  

  • 8. Countercurrents: Is now the right time to pull the plug on mammography?
    Narod SA
    Curr Oncol; 2019 Jun; 26(3):162-163. PubMed ID: 31285658
    [No Abstract]   [Full Text] [Related]  

  • 9. Countercurrents: The bias of choice.
    Narod SA
    Curr Oncol; 2019 Dec; 26(6):e712-e713. PubMed ID: 31896940
    [No Abstract]   [Full Text] [Related]  

  • 10. Introducing Countercurrents-a new feature of Current Oncology.
    Foulkes WD
    Curr Oncol; 2011 Oct; 18(5):203. PubMed ID: 21980243
    [No Abstract]   [Full Text] [Related]  

  • 11. Countercurrents: The Last Trial.
    Narod SA
    Curr Oncol; 2021 Jan; 28(1):275-277. PubMed ID: 33466519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Countercurrents: Is now the right time to pull the plug on mammography?
    Coldman A; Doyle G; Payne J
    Curr Oncol; 2019 Dec; 26(6):e793. PubMed ID: 31896951
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell biology: Countercurrents in lipid flow.
    Menon AK; Levine TP
    Nature; 2015 Sep; 525(7568):191-2. PubMed ID: 26354476
    [No Abstract]   [Full Text] [Related]  

  • 14. [CURRENTS AND COUNTERCURRENTS IN THE KIDNEYS. II. NEW CONCEPT OF THE REGULATION OF RENAL OSMOSIS].
    WIJDEVELD PG
    Ned Tijdschr Geneeskd; 1964 Jun; 108():1133-7. PubMed ID: 14161733
    [No Abstract]   [Full Text] [Related]  

  • 15. Leveraging Bayesian networks and information theory to learn risk factors for breast cancer metastasis.
    Jiang X; Wells A; Brufsky A; Shetty D; Shajihan K; Neapolitan RE
    BMC Bioinformatics; 2020 Jul; 21(1):298. PubMed ID: 32650714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of N-terminal pro-brain natriuretic peptide to assess left ventricular function after adjuvant doxorubicin therapy in early breast cancer patients: a prospective series.
    Cil T; Kaplan AM; Altintas A; Akin AM; Alan S; Isikdogan A
    Clin Drug Investig; 2009; 29(2):131-7. PubMed ID: 19133708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Countercurrents from the West: “blue-eyed” Zen masters, Vipassanā meditation, and Buddhist psychotherapy in contemporary Korea.
    Bongseok Joo R
    J Am Acad Relig; 2011; 79(3):614-38. PubMed ID: 22145173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian breast skin temperature rhythms: overt and occult benign and occult primary malignant breast disease.
    Wilson DW; George D; Mansel RE; Simpson HW; Halberg F; Griffiths K
    Chronobiol Int; 1984; 1(2):167-72. PubMed ID: 6600022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitude towards genetic testing for breast cancer susceptibility: a comparison of affected and unaffected women.
    Bruno M; Digennaro M; Tommasi S; Stea B; Danese T; Schittulli F; Paradiso A
    Eur J Cancer Care (Engl); 2010 May; 19(3):360-8. PubMed ID: 19912305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-environment interactions in breast cancer.
    Chia KS
    Novartis Found Symp; 2008; 293():143-50; discussion 150-5, 181-3. PubMed ID: 18972750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.